Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Farmers urged to vaccinate against bluetongue
Cow
Cattle are the main carriers of Bluetongue.

Vaccine available later this month

Farming minister George Eustice is urging livestock producers to consider vaccinating their animals against bluetongue, Farmers Weekly report.

Speaking ahead of the the Livestock Event at the NEC, Birmingham on Wednesday (6 July), Mr Eustice called on livestock farmers to keep a look out for any signs of the disease and report any suspicions to their vet and the APHA immediately.

“As ever, we will work closely with farmers, industry bodies and vets to make sure we’re well-prepared for a possible outbreak to minimise any impact on livelihoods,” he said.

Bluetongue is a non-contagious disease that affects sheep, cows, goats and camelids. In sheep, the main signs of bluetongue are ulcers in the mouth, drooling from the mouth and nose, and swelling of the mouth, head and neck.

Cattle are the main carriers of Bluetongue. However, they generally do not show any signs of the disease. Occasional signs can include swelling and ulcers in the mouth, nasal discharge, swollen teats, tiredness and red skin.

Experts believe that there is a high risk of bluetongue type 8 spreading towards the UK later this summer, as a result of infected midges being blown over from France.

In response to the warning, MSD Animal Health signed an agreement with the Spanish-based biopharmaceutical specialist CZ Veterinaria SA (CZV), to distribute its bluetongue vaccine (BLUEVAC BTV8) throughout Great Britain.  

The company expects the vaccine, which has been used in Europe for a number of years, to become available in the UK later this month. 

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.